Last updated on 7 Apr 2022
Owner Info
Ligand Pharmaceuticals Incorporated
5980 Horton Street, Suite 405
Emeryville CA 94608, UNITED STATES OF AMERICA
Serial Number
2052234 filed on 27 Sept 2019
Correspondent
Lisa M. Martens Sheppard Mullin Richter & Hampton LLP
12275 El Camino Real, Suite 200,
San Diego CA 92130-2006,
UNITED STATES OF AMERICA
2052234
27 Sept 2019
27 Sept 2029
FIGURATIVE
29 Mar 2019
US
Status Date | Action Taken |
---|---|
7th Apr 2022 | Amendment to Amend Owner Requested |
12th May 2020 | International Registration in Australia Protected correspondence sent |
11th May 2020 | IP Right Registration Published |
11th May 2020 | Status change to Registered/Protected |
4th Mar 2020 | Application Accepted correspondence sent |
3rd Mar 2020 | IP Right has been Examined |
3rd Mar 2020 | IP Right Acceptance Published |
3rd Mar 2020 | Status change to Accepted |
26th Nov 2019 | Examination expedited |
26th Nov 2019 | Awaiting examination |